The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Sep. 12, 2013
Applicants:

James Astwood, Alameda, CA (US);

Michelle L. Collins, Oakland, CA (US);

Brian Connolly, Hayward, CA (US);

Inventors:

James Astwood, Alameda, CA (US);

Michelle L. Collins, Oakland, CA (US);

Brian Connolly, Hayward, CA (US);

Assignee:

AURORA ALGAE, INC., Hayward, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23L 1/30 (2006.01); A61K 31/201 (2006.01); A61K 31/202 (2006.01); A61K 31/661 (2006.01); A61K 31/7028 (2006.01); A61K 36/02 (2006.01); C12N 15/82 (2006.01); C12P 7/64 (2006.01); A61K 31/231 (2006.01); A61K 31/683 (2006.01); A61K 31/7012 (2006.01); C11C 1/02 (2006.01); C11B 3/00 (2006.01); C11C 3/08 (2006.01); A23D 9/00 (2006.01); A21D 2/16 (2006.01); A61K 31/20 (2006.01); A23L 1/337 (2006.01); A23L 2/04 (2006.01);
U.S. Cl.
CPC ...
A23L 1/3008 (2013.01); A21D 2/165 (2013.01); A23D 9/00 (2013.01); A23L 1/3006 (2013.01); A23L 1/337 (2013.01); A23L 2/04 (2013.01); A61K 31/20 (2013.01); A61K 31/201 (2013.01); A61K 31/202 (2013.01); A61K 31/231 (2013.01); A61K 31/661 (2013.01); A61K 31/683 (2013.01); A61K 31/7012 (2013.01); A61K 31/7028 (2013.01); A61K 36/02 (2013.01); C11B 3/001 (2013.01); C11C 1/02 (2013.01); C11C 3/08 (2013.01); C12N 15/8247 (2013.01); C12P 7/6427 (2013.01); A23V 2002/00 (2013.01);
Abstract

Provided herein are exemplary compositions, products, and capsules utilizing POA, EPA, blends of POA and EPA, total algal oil compositions, and/or whole biomass compositions in methods of inhibiting inflammation including in cardiovascular disease, diabetes, obesity, stroke, metabolic syndromes, dementia, Alzheimer's disease, and/or cancer. The exemplary compositions, products, and capsules may be orally, topically, intravenously, and/or subcutaneously administered. The exemplary compositions herein may be used as feed, food, food supplements, beverages, beverage supplements, nutritional products, products for athletic performance, pharmaceutical products, and/or medical products for mammalian use, including humans.


Find Patent Forward Citations

Loading…